新型抗生素-话题@MedSci

#新型抗生素#

40篇内容 | 600人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1676880, encodeId=b92016e6880d8, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=新型抗生素！国家1类新药纽再乐®获批上市，应对多重耐药细菌, objectType=article, longId=291885, objectId=36dc2918856a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36dc2918856a, replyNumber=0, likeNumber=26, createdTime=2022-01-01, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36dc2918856a, moduleTitle=新型抗生素！国家1类新药纽再乐®获批上市，应对多重耐药细菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36dc2918856a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676881, encodeId=eb6f16e688131, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=Science：新型抗生素cilagicin有望对抗耐药性病原菌, objectType=article, longId=728331, objectId=77d1e2833166, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77d1e2833166, replyNumber=0, likeNumber=28, createdTime=2023-05-15, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77d1e2833166, moduleTitle=Science：新型抗生素cilagicin有望对抗耐药性病原菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77d1e2833166)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676877, encodeId=502b16e687767, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=新型抗生素在艰难梭菌II期研究中显示出强大的治疗潜力, objectType=article, longId=203616, objectId=faa220361607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faa220361607, replyNumber=0, likeNumber=42, createdTime=2020-11-26, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faa220361607, moduleTitle=新型抗生素在艰难梭菌II期研究中显示出强大的治疗潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faa220361607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676879, encodeId=85af16e6879d4, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=Nat Com：新型抗生素单次清除小鼠耐药性淋病, objectType=article, longId=208894, objectId=58a92088946c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58a92088946c, replyNumber=0, likeNumber=33, createdTime=2021-11-10, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58a92088946c, moduleTitle=Nat Com：新型抗生素单次清除小鼠耐药性淋病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58a92088946c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676878, encodeId=dce316e687829, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=NICE将新型抗生素Fetcroja（cefiderocol）纳入试点报销范围, objectType=article, longId=205044, objectId=c2e52050447d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2e52050447d, replyNumber=0, likeNumber=27, createdTime=2021-09-11, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2e52050447d, moduleTitle=NICE将新型抗生素Fetcroja（cefiderocol）纳入试点报销范围, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2e52050447d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676875, encodeId=3acc16e6875b5, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=CELL：时隔多年，终于发现革兰氏阴性菌新型抗生素！, objectType=article, longId=195293, objectId=3856195293de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3856195293de, replyNumber=0, likeNumber=32, createdTime=2021-04-08, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3856195293de, moduleTitle=CELL：时隔多年，终于发现革兰氏阴性菌新型抗生素！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3856195293de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676876, encodeId=340e16e68766e, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=随着抗菌素耐药性加剧，默沙东的新型抗生素组合Recarbrio在英国上市, objectType=article, longId=203565, objectId=f49420356502, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f49420356502, replyNumber=0, likeNumber=23, createdTime=2021-09-09, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f49420356502, moduleTitle=随着抗菌素耐药性加剧，默沙东的新型抗生素组合Recarbrio在英国上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f49420356502)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676873, encodeId=8d5916e687391, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=欧盟批准Shionogi的新型抗生素Fetcroja——用于WHO指定的所有重点革兰氏阴性病原体, objectType=article, longId=193318, objectId=de90193318ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de90193318ff, replyNumber=0, likeNumber=24, createdTime=2020-08-20, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de90193318ff, moduleTitle=欧盟批准Shionogi的新型抗生素Fetcroja——用于WHO指定的所有重点革兰氏阴性病原体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de90193318ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676874, encodeId=c91516e6874d6, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=再鼎医药新型抗生素——奥玛环素上市申请获NMPA优先审评, objectType=article, longId=193902, objectId=a4ea193902d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4ea193902d3, replyNumber=0, likeNumber=30, createdTime=2020-06-11, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4ea193902d3, moduleTitle=再鼎医药新型抗生素——奥玛环素上市申请获NMPA优先审评, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4ea193902d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676872, encodeId=fde516e687204, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=Nature：用于革兰氏阴性菌的新型抗生素, objectType=article, longId=181991, objectId=cffd181991ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cffd181991ff, replyNumber=0, likeNumber=19, createdTime=2020-06-14, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cffd181991ff, moduleTitle=Nature：用于革兰氏阴性菌的新型抗生素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cffd181991ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676870, encodeId=972116e6870ac, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=Procarta获得150万欧元资助用于新型抗生素的研发以抗击抗菌素耐药性, objectType=article, longId=161793, objectId=206b161e93a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=206b161e93a1, replyNumber=0, likeNumber=19, createdTime=2019-12-07, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=206b161e93a1, moduleTitle=Procarta获得150万欧元资助用于新型抗生素的研发以抗击抗菌素耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=206b161e93a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676866, encodeId=ef2016e6866a4, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=Nature：发现对革兰氏阴性菌具有抗菌活性的新型抗生素, objectType=article, longId=148833, objectId=4f481488334f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f481488334f, replyNumber=0, likeNumber=35, createdTime=2019-07-25, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f481488334f, moduleTitle=Nature：发现对革兰氏阴性菌具有抗菌活性的新型抗生素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f481488334f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676871, encodeId=63e316e6871b0, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=生物武器的克星：新型抗生素DNV3681, objectType=article, longId=172179, objectId=41e51e2179be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41e51e2179be, replyNumber=0, likeNumber=28, createdTime=2019-09-21, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41e51e2179be, moduleTitle=生物武器的克星：新型抗生素DNV3681, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41e51e2179be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676868, encodeId=c8fb16e6868f6, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=盟科医药新型抗生素Contezolid Acefosamil美国二期临床试验顺利完成首例患者入组, objectType=article, longId=154428, objectId=c05f154428fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c05f154428fa, replyNumber=0, likeNumber=23, createdTime=2019-08-12, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c05f154428fa, moduleTitle=盟科医药新型抗生素Contezolid Acefosamil美国二期临床试验顺利完成首例患者入组, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c05f154428fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676867, encodeId=240716e686795, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=NEJM：新型抗生素有望对抗“超级淋病”, objectType=article, longId=153153, objectId=393d1531536d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=393d1531536d, replyNumber=0, likeNumber=18, createdTime=2019-09-15, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=393d1531536d, moduleTitle=NEJM：新型抗生素有望对抗“超级淋病”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=393d1531536d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676869, encodeId=b6cb16e68692a, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=FDA批准MGB Biopharma的新型抗生素IND申请治疗艰难梭菌相关性腹泻, objectType=article, longId=158875, objectId=0f461588e508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f461588e508, replyNumber=0, likeNumber=22, createdTime=2019-02-21, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f461588e508, moduleTitle=FDA批准MGB Biopharma的新型抗生素IND申请治疗艰难梭菌相关性腹泻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f461588e508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676865, encodeId=d73016e6865c9, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=Motif Bio的新型抗生素iclaprim获得美国优先审查, objectType=article, longId=146657, objectId=966d14665ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=966d14665ef3, replyNumber=0, likeNumber=20, createdTime=2019-01-23, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=966d14665ef3, moduleTitle=Motif Bio的新型抗生素iclaprim获得美国优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=966d14665ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676863, encodeId=970616e686331, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=Nature：科学家Nature发文，有望助力新型抗生素研发, objectType=article, longId=137437, objectId=0eb413e43771, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0eb413e43771, replyNumber=0, likeNumber=27, createdTime=2018-06-06, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0eb413e43771, moduleTitle=Nature：科学家Nature发文，有望助力新型抗生素研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eb413e43771)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676864, encodeId=d5c116e68649d, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=Nabriva新型抗生素Lefamulin的胃肠道副作用, objectType=article, longId=138883, objectId=031013888329, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=031013888329, replyNumber=0, likeNumber=24, createdTime=2018-11-28, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=031013888329, moduleTitle=Nabriva新型抗生素Lefamulin的胃肠道副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=031013888329)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1676862, encodeId=433c16e68621f, content=<a href='/topic/show?id=63825823146' target=_blank style='color:#2F92EE;'>#新型抗生素#</a>, objectTitle=【研发日报】Nabriva公司新型抗生素lefamulin显示肺炎疗效, objectType=article, longId=113368, objectId=b162113368e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b162113368e8, replyNumber=0, likeNumber=23, createdTime=2018-06-23, rootId=0, userName=marongnuan, userId=8bab27396846, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b162113368e8, moduleTitle=【研发日报】Nabriva公司新型抗生素lefamulin显示肺炎疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b162113368e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

新型抗生素！国家1类新药纽再乐®获批上市，应对多重耐药细菌

2022-01-01

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

Science：新型抗生素cilagicin有望对抗耐药性病原菌

2023-05-15

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

新型抗生素在艰难梭菌II期研究中显示出强大的治疗潜力

2020-11-26

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

Nat Com：新型抗生素单次清除小鼠耐药性淋病

2021-11-10

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

NICE将新型抗生素Fetcroja（cefiderocol）纳入试点报销范围

2021-09-11

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

CELL：时隔多年，终于发现革兰氏阴性菌新型抗生素！

2021-04-08

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

随着抗菌素耐药性加剧，默沙东的新型抗生素组合Recarbrio在英国上市

2021-09-09

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

欧盟批准Shionogi的新型抗生素Fetcroja——用于WHO指定的所有重点革兰氏阴性病原体

2020-08-20

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

再鼎医药新型抗生素——奥玛环素上市申请获NMPA优先审评

2020-06-11

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

Nature：用于革兰氏阴性菌的新型抗生素

2020-06-14

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

Procarta获得150万欧元资助用于新型抗生素的研发以抗击抗菌素耐药性

2019-12-07

marongnuan (审核中...)

前往app查看评论内容

#新型抗生素#

Nature：发现对革兰氏阴性菌具有抗菌活性的新型抗生素

2019-07-25

marongnuan (审核中...)